Wnt-1 signal induces, phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK

Genes and Development

Volumn 18, Issue 7, 2004, Pages 816-829

  Kanei Ishii, Chie ^a   Ninomiya Tsuji, Jun ^c   Tanikawa, Jun ^a   Nomura, Teruaki ^a   Ishitani, Tohru ^c   Kishida, Satoshi ^c   Kokura, Kenji ^a   Kurahashi, Toshihiro ^a,b   Ichikawa Iwata, Emi ^a   Kim, Yongsok ^d   Matsumoto, Kunihiro ^c   Ishii, Shunsuke ^a,b  

^a RIKEN TSUKUBA INSTITUTE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Degradation; HIPK2; Myb; NLK; Phosphorylation; TAK1

Indexed keywords

HOMEODOMAIN INTERACTING PROTEIN KINASE 2; NEMO LIKE KINASE; PROTEIN C MYB; PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE; UNCLASSIFIED DRUG; WNT1 PROTEIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DEGRADATION; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTO ONCOGENE; UBIQUITINATION;

ANIMALS; CARRIER PROTEINS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DOWN-REGULATION; GLUTATHIONE TRANSFERASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOID; MAP KINASE KINASE KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MITOGENS; NUCLEAR PROTEINS; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; RNA, SMALL INTERFERING; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN; WNT PROTEINS; WNT1 PROTEIN; ZEBRAFISH PROTEINS;

EID: 11144355861     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1170604     Document Type: Article

References (62)

1. Allen III, R.D., Bender, T.P., and Siu, G. 1999. c-Myb is essential for early T-cell development. Genes & Dev. 13: 1073-1078.
2. Aziz, N., Miglarese, M.R., Hendrickson, R.C., Shabanowitz, J., Sturgill, T.W., Hunt, D.F., and Bender, T.P. 1995. Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain. Proc. Natl. Acad. Sci. 92: 6429-6433.
3. Behrens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. 1996. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638-642.
4. Behrens, J., Jerchow, B.A., Wurtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kuhl, M., Wedlich, D., and Birchmeier, W. 1998. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 280: 596-599.
5. Biedenkapp, H., Borgmeyer, U., Sippel, A.E., and Klempnauer, K.-H. 1988. Viral myb oncogene encodes a sequence-specific DNA binding activity. Nature 335: 835-837.
6. Bies, J. and Wolff, L. 1997. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway. Oncogene 14: 203-212.
7. Brandon, C., Eisenberg, L.M., and Eisenberg, C.A. 2000. WNT signaling modulates the diversification of hematopoietic cells. Blood 96: 4132-4141.
8. Brott, B.K., Pinsky, B.A., and Erikson, R.L. 1998. Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus. Proc. Natl. Acad. Sci. 95: 963-968.
9. Choi, C.Y., Kim, Y.H., Kwon, H.J., and Kim, Y. 1999. The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription. J. Biol. Chem. 274: 33194-33197.
10. Dai, P., Akimaru, H., Tanaka, Y., Hou, D.X., Yasukawa, T., Kanei-Ishii, C., Takahashi, T., and Ishii, S. 1996. CBP as a transcriptional coactivator of c-Myb. Genes & Dev. 10: 528-540.
11. Dini, P.W. and Lipsick, J.S. 1993. Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo. Mol. Cell. Biol. 13: 7334-7348.
12. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., Del Sal, G., et al. 2002. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 4: 11-19.
13. Dubendorff, J.W., Whittaker, L.J., Eltman, J.T., and Lipsick, J.S. 1992. Carboxyl-terminal elements of c-Myb negatively regulate transcriptional activation in cis and in trans. Genes & Dev. 6: 2524-2535.
14. Frampton, J., Ramqvist, T., and Graf, T. 1996. v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes & Dev. 10: 2720-2731.
15. Ghosh, S. and Karin, M. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl): 81-96.
16. Gonda, T.J. and Metcalf, D. 1984. Expression of myb, myc, and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature 310: 249-251.
17. Harada, J., Kokura, K., Kanei-Ishii, C., Nomura, T., Khan, M.M., Kim, Y., and Ishii, S. 2003. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation. J. Biol. Chem. 278: 38998-39005.
18. Hofmann, T.G., Moller, A., Sirma, H., Zentgraf, H., Taya, Y., Droge, W., Will, H., and Schmitz, M.L. 2002. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 4: 1-10.
19. Hu, L.-Y., Ramsay, R.G., Kanei-Ishii, C., Ishii, S., and Gonda, T.J. 1991. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain. Oncogene 6: 1549-1553.
20. Ishitani, T., Ninomiya-Tsuji, J., Nagai, S., Nishita, M., Meneghini, M., Barker, N., Waterman, M., Bowerman, B., Clevers, H., Shibuya, H., et al. 1999. The TAK1-NLK-MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCF. Nature 399: 798-802.
21. 2+ pathway to antagonize Wnt/β-catenin signaling. Mol. Cell. Biol. 23: 131-139.
22. Jiang, J. and Struhl, G. 1998. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature 391: 493-496.
23. Kanei-Ishii, C., MacMillan, E.M., Nomura, T., Sarai, A., Ramsay, R.G., Aimoto, S., Ishii, S., and Gonda, T.J. 1992. Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc. Natl. Acad. Sci. 89: 3088-3092.
24. Katzen, A.L., Jackson, J., Harmon, B.P., Fung, S.M., Ramsay, G., and Bishop, J.M. 1998. Drosophila myb is required for the G2/M transition and maintenance of diploidy. Genes & Dev. 12: 831-843.
25. Kim, Y.H., Choi, C.Y., Lee, S.J., Conti, M.A., and Kim, Y. 1998. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J. Biol. Chem. 273: 25875-25879.
26. Kishimoto, K., Matsumoto, K., and Ninomiya-Tsuji, J. 2000. TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J. Biol. Chem. 275: 7359-7364.
27. Klempnauer, K.-H., Gonda, T.J., and Bishop, J.M. 1982. Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell 31: 453-463.
28. Kowenz-Leutz, E., Herr, P., Niss, K., and Leutz, A. 1997. The homeobox gene GBX2, a target of the myb oncogene, mediates autocrine growth and monocyte differentiation. Cell 91: 185-195.
29. 2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet. 16: 279-283.
30. Leverson, J.D., Koskinen, P.J., Orrico, F.C., Rainio, E.M., Jalkanen, K.J., Dash, A.B., Eisenman, R.N., and Ness, S.A. 1998. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol. Cell 2: 417-425.
31. Liang, H., Chen, Q., Coles, A.H., Anderson, S.J., Pihan, G., Bradley, A., Gerstein, R., Jurecic, R., and Jones, S.N. 2003. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4: 349-360.
32. Lüscher, B., Christenson, E., Litchfield, D.W., Krebs, E.G., and Eisenman, R.N. 1990. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature 344: 517-522.
33. Meneghini, M.D., Ishitani, T., Carter, J.C., Hisamoto, N., Ninomiya-Tsuji, J., Thorpe, C.J., Hamill, D.R., Matsumoto, K., and Bowerman, B. 1999. MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans. Nature 399: 793-797.
34. Mizuguchi, G., Nakagoshi, H., Nagase, T., Nomura, N., Date, T., Ueno, Y., and Ishii, S. 1990. DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB. J. Biol. Chem. 265: 9280-9284.
35. Mucenski, M.L., McLain, K., Kier, A.B., Swerdlow, S.H., Schereiner, C.M., Miller, T.A., Pietryga, D.W., Scott, W.J., and Potter, S.S. 1991. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65: 677-689.
36. Nakagoshi, H., Kanei-Ishii, C., Sawazaki, T., Mizuguchi, G., and Ishii, S. 1992. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7: 1233-1240.
37. Ness, S.A., Marknell, A., and Graf, T. 1989. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 59: 1115-1125.
38. Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., and Matsumoto, K. 1999. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398: 252-256.
39. Nomura, T. Khan, M.M., Kaul, S.C., Dong, H.D., Wadhwa, R., Colmenares, C., Kohno, I., and Ishii, S. 1999. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes & Dev. 13: 412-423.
40. Ogata, K., Morikawa, S., Nakamura, H., Sekikawa, A., Inoue, T., Kanai, H., Sarai, A., Ishii, S., and Nishimura, Y. 1994. Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices. Cell 79: 639-648.
41. Okada, M., Akimaru, H., Hou, D.-X., Takahashi, T., and Ishii, S. 2002. Myb controls G2/M progression by inducing cyclin B expression in the Drosophila eye imaginal disc. EMBO J. 21: 675-684.
42. Pandur, P. and Kuhl, M. 2001. An arrow for wingless to take-off. Bioessays 23: 207-210.
43. Peifer, M. and Polakis, P. 2000. Wnt signaling in oncogenesis and embryogenesis: A look outside the nucleus. Science 287: 1606-1609.
44. Reya, T., Duncan, A.W., Ailles, L., Domen, J., Scherer, D.C., Willert, K., Hintz, L., Nusse, R., and Weissman, I.L. 2003. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423: 409-414.
45. Rocheleau, C.E., Yasuda, J., Shin, T.H., Lin, R., Sawa, H., Okano, H., Priess, J.R., Davis, R.J., and Mello, C.C. 1999. WRM-1 activates the LIT-1 protein kinase to transduce anterior/posterior polarity signals in C. elegans. Cell 97: 717-726.
46. Sakura, H., Kanei-Ishii, C., Nagase, T., Nakagoshi, H., Gonda, T.J., and Ishii, S. 1989. Delineation of the three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc. Natl. Acad. Sci. 86: 5758-5762.
47. Schmidt, M., Nazarov, V., Stevens, L., Watson, R., and Wolff, L. 2000. Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis. Mol. Cell. Biol. 20: 1970-1981.
48. Selvakumaran, M., Liebermann, D.A., and Hoffman-Liebermann, B. 1992. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: Role in leukemogenesis. Mol. Cell. Biol. 12: 2493-2500.
49. Shibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N., Irie, K., Nishida, E., and Matsumoto, K. 1996. TAB1: An activator of the TAK1 MAPKKK in TGF-β signal transduction. Science 272: 1179-1182.
50. Shin, T.H., Yasuda, J., Rocheleau, C.E., Lin, R., Soto, M., Bei, Y., Davis, R.J., and Mello, C.C. 1999. MOM-4, a MAP kinase kinase kinase-related protein, activates WRM-1/LIT-1 kinase to transduce anterior/posterior polarity signals in C. elegans. Mol. Cell 4: 275-280.
51. Shinagawa, T., Nomura, T., Colmenares, C., Ohira, M., Nakagawara, A., and Shunsuke Ishii, S. 2001. Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice. Oncogene 20: 8100-8108.
52. Takaesu, G., Surabhi, R.M., Park, K.J., Ninomiya-Tsuji, J., Matsumoto, K., and Gaynor, R.B. 2003. TAK1, is critical for IκB kinase-mediated activation of the NF-κB pathway. J. Mol. Biol. 26: 105-115.
53. Tanikawa, J., Yasukawa, T., Enari, M., Ogata, K., Nishimura, Y., Ishii, S. and Sarai, A. 1993. Recognition of specific DNA sequences by the c-myb proto-oncogene product: role of three repeat units in the DNA-binding domain. Proc. Natl. Acad. Sci. 90: 9320-9324.
54. Taylor, D., Badiani, P., and Weston, K. 1996. A dominant interfering Myb mutant causes apoptosis in T cells. Genes & Dev. 10: 2732-2744.
55. Weston, C.R. and Davis, R.J. 2002. The JNK signal transduction pathway. Curr. Opin. Genet. Dev. 12: 14-21.
56. Weston, K. and Bishop, J.M. 1989. Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell 58: 85-93.
57. Winston, J.T., Strack, P., Beer-Romero, P., Chu, C.Y., Elledge, S.J., and Harper, J.W. 1999. The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes & Dev. 13: 270-283.
58. Wodarz, A. and Nusse, R. 1998. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14: 59-88.
59. Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., and Matsumoto, K. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270: 2008-2011.
60. Yasukawa, T., Kanei-Ishii, C., Maekawa, T., Fujimoto, J., Yamamoto, T., and Ishii, S. 1995. Increase of solubility of foreign proteins in Escherichia coli by coproduction of the bacterial thioredoxin. J. Biol. Chem. 270: 25328-25331.
61. Zeng, L., Fagotto, F., Zhang, T., Hsu, W., Vasicek, T.J., Perry III, W.L., Lee, J.J., Tilghman, S.M., Gumbiner, B.M., and Costantini, F. 1997. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90: 181-192.
62. Zhang, Q., Yoshimatsu, Y., Hildebrand, J., Frisch, S.M., and Goodman, R.H. 2003. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 115: 177-186.